Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETX-018810 in lumbosacral radicular pain
NCT04778592Phase 2Completed
- Sponsor
- Tenet Medicines
- Start
- Jan 2021
- Primary completion
- May 2022
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ETX-018810 in lumbosacral radiculopathy, sponsored by Tenet Medicines. Started Jan 2021; status: completed.
02
Drugs
ETX-018810
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT04778592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778592.